Loading clinical trials...
Loading clinical trials...
Efficacy and Safety of Adapalene Gel 0.3% in the Treatment of Atrophic Acne Scars. A Pilot Study.
The purpose of this study is to assess the efficacy and safety of Adapalene Gel 0.3% in the treatment of atrophic acne scars.
Age
18 - 50 years
Sex
ALL
Healthy Volunteers
No
Manisha PATEL
Baltimore, Maryland, United States
Start Date
March 1, 2011
Primary Completion Date
April 1, 2012
Completion Date
September 1, 2012
Last Updated
February 18, 2021
20
ACTUAL participants
Adapalene
DRUG
Lead Sponsor
Galderma R&D
NCT07058883
NCT07368764
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT07151599